Literature DB >> 1907432

Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis.

J Sloth-Nielsen1, B Guldager, C Mouritzen, E B Lund, M Egeblad, O Nørregaard, S J Jørgensen, R Jelnes.   

Abstract

In a randomized, double-blind, controlled study, 153 patients with claudication were each given either 20 infusions of Na2EDTA or 20 infusions of saline. Walking distances and ankle/brachial indices were measured before, during, and after treatment. In 30 patients, angiograms and transcutaneous oxygen tensions were obtained before, during, and after treatment. The patients' subjective evaluations of the effect of treatment were also recorded. It is concluded that EDTA chelation therapy has no effect in patients with intermittent claudication in the legs caused by arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907432     DOI: 10.1016/0002-9610(91)90172-a

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

Review 1.  Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.

Authors:  Ehimen C Aneni; Esteban Escolar; Gervasio A Lamas
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

2.  Opinions on chelation therapy in patients undergoing coronary angiography: cross-sectional survey.

Authors:  Hude Quan; P Diane Galbraith; Colleen M Norris; Danielle A Southern; Kathryn King; Marja J Verhoef; Marril L Knudtson; William A Ghali
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

3.  Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.

Authors:  Kimball C Atwood; Elizabeth Woeckner; Robert S Baratz; Wallace I Sampson
Journal:  Medscape J Med       Date:  2008-05-13

Review 4.  EDTA chelation therapy for cardiovascular disease: a systematic review.

Authors:  Dugald M R Seely; Ping Wu; Edward J Mills
Journal:  BMC Cardiovasc Disord       Date:  2005-11-01       Impact factor: 2.298

5.  Chelation therapy for atherosclerotic cardiovascular disease.

Authors:  Maria Vanessa Villarruz-Sulit; Rachel Forster; Antonio L Dans; Flordeliza N Tan; Dennis V Sulit
Journal:  Cochrane Database Syst Rev       Date:  2020-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.